SIGLEC5: An immune checkpoint ligand in sepsis.
Lozano-Rodriguez, R.; Avendano-Ortiz, J.; Montalban-Hernandez, K.; Ruiz-Rodriguez, J. C.; Ferrer, R.; Martin-Quiros, A.; Maroun-Eid, C.; Gonzalez-Lopez, J. J.; Fabrega, A.; Terron, V.; del Fresno, C.; Toledano, V.; Marin, E.; Guitierrez-Fernandez, M.; Alonso-Lopez, E.; Cubillos-Zapata, C.; Stringa, P.; Perez de Diego, R.; Pelegrin, P.; Garcia-Palenciano, C.; Valentin, J.; Gomez-Campelo, P.; Aguirre, L. A.; Lopez-Collazo, E.
Show abstract
Sepsis is a global health priority. Despite thorough studies in mice models, its molecular and cellular basis remain unclear and there is no pharmacological effective treatment other than antimicrobial and supportive therapy. During sepsis, T cells exhaustion compromises patients outcome, and immune checkpoints (ICs) become crucial players in disease management. Here, a total of 425 patients with systemic inflammatory response criteria and 127 controls were studied. Soluble SIGLEC5 (sSIGLEC5) levels in plasma were higher in patients with sepsis compared to the other groups and even higher in those patients with septic-shock. sSIGLEC5 plasma levels were higher in non-survivors than in survivors and ROC curves analysis revealed sSIGLEC5 as a survival marker (cut-off [≤] 523.6 ng/mL). In vitro experiments illustrated how SIGLEC5 impaired CD8+ proliferation through binding to PSGL1. Blocking the SIGLEC5/PSGL1 axis reverted the latter effect. Mechanistically, SIGLEC5 overexpression was driven by HIF1. Exogenous sSIGLEC5 accelerated death and magnified acute lung injury in mice models. Our data demonstrates how plasma sSIGLEC5 level on admission predicts death and stratifies patients with sepsis. This molecule exhibits the hallmarks of an IC ligand.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and stratifies outcomes in severe COVID-19 93%
- Elevated plasma cholesterol causally improves sepsis outcome by promoting hepatic metabolic reprogramming 93%
- Time-Dependent Variation in Immunoparalysis Biomarkers Among Patients with Sepsis and Critical Illness 93%
Similar papers in this journal
Similar papers in this journal
- Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks 93%
- Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation 90%
- SARS-CoV-2-Triggered Mast Cell Rapid Degranulation Induces Alveolar Epithelial Inflammation and Lung Injury 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.